Sign in:
Email
 Password  save:
  
 Company Reports 
 
   
My Recent Searches
  Help
 
   
 
 
Get Insiders for : 
Transmedics Group, Inc. (TMDX)  
$127.22 0.06 (0.05%) as of 4:30 Wed 5/8


Download
   
Exchange: N/A
Security Type: Common
Shares Out: 35,915,000
Market Cap: 4.57(B)
Last Volume: 0 Avg Vol: 0
52 Week Range: $36.74 - $124.44
Level I Sector: N/A
Level II Sector: N/A
Level III Sector: N/A

Member Indexes:

   

Rankings:

     
Insider 3 Months    :   -
Insider 6 Months    :   -
Insider 3/6 Months :   -
Guru Rank Number :  -
Guru Rank Value     :  -
Guru Occurances    :  -

 

            6 Months   1 Year   2 Year  
 
Company Profile   TransMedics Group is a commercial-stage medical technology company transforming organ transplant therapy for end-stage organ failure patients across various disease states. Co. has developed the Organ Care System (OCS), a portable organ perfusion and monitoring system that using Co.'s technology to replicate near-physiologic conditions for donor organs outside of the human body. The OCS was designed to perfuse donor organs with warm, oxygenated and nutrient-enriched blood, while maintaining the organs in a living, functioning state; the lung is breathing, the heart is beating and the liver is producing bile. Co.'s OCS products are one for each of lung, heart and liver transplantations.


 
 
Summary  (Direct Transactions Only) 3 Months 6 Months 12 Months 24 Months
Total Shares Bought 0 0 2,500 2,500
Total Buy Value $0 $0 $155,000 $155,000
Total People Bought 0 0 1 1
Total Buy Transactions 0 0 1 1
Total Shares Sold 271,054 342,899 405,806 1,060,395
Total Sell Value $27,491,657 $33,196,965 $37,923,912 $74,654,923
Total People Sold 4 6 6 10
Total Sell Transactions 21 30 40 119
End Date 2024-02-08 2023-11-07 2023-05-09 2022-05-09

   
Records found: 366
  Page 7 of 15  
Filer's Name Relation Title Off-Dir-10% Tran. Date Form Action Price Mkt Value D/I Shares Holdings
Rank

 
3m +/-  
Form
   Provost Miriam VP, Global Regulatory Affairs   •       –      –    2022-12-09 4 S $59.00 $213,167 D/D (3,613) 13,551 -51%     
   Provost Miriam VP, Global Regulatory Affairs   •       –      –    2022-12-09 4 OE $16.14 $171,500 D/D 5,126 14,118     -
   Carey John F VP of Operations   •       –      –    2022-12-05 4 OE $0.28 $10 D/D 36 13,844     -
   Carey John F VP of Operations   •       –      –    2022-12-02 4 AS $63.50 $635,000 D/D (10,000) 13,808 3%     
   Carey John F VP of Operations   •       –      –    2022-12-02 4 OE $0.28 $388,250 D/D 23,037 23,808     -
   Gordon Stephen Chief Financial Officer   •       –      –    2022-12-01 4 AS $61.30 $613,026 D/D (10,000) 5,714 14%     
   Gordon Stephen Chief Financial Officer   •       –      –    2022-12-01 4 OE $16.14 $161,400 D/D 10,000 15,714     -
   Khayal Tamer I Chief Commercial Officer   •       –      –    2022-12-01 4 OE $2.21 $24,423 I/I 11,051 11,051     -
   Carey John F VP of Operations   •       –      –    2022-12-01 4 AS $60.83 $183,873 D/D (3,000) 771 14%     
   Carey John F VP of Operations   •       –      –    2022-12-01 4 OE $0.28 $840 D/D 3,000 3,771     -
   Lovell Stephanie Director   –       •      –    2022-11-23 4 S $59.50 $336,592 D/D (5,657) 0 -21%     
   Lovell Stephanie Director   –       •      –    2022-11-23 4 OE $47.82 $270,518 D/D 5,657 5,657     -
   Lovell Stephanie Director   –       •      –    2022-11-22 4 S $57.97 $284,130 D/D (4,900) 0 -21%     
   Lovell Stephanie Director   –       •      –    2022-11-22 4 OE $26.26 $210,602 D/D 4,900 1,100     -
   Hassanein Waleed H President & CEO   •       •      –    2022-11-15 4 AS $60.13 $870,863 D/D (14,483) 426,285 28%     
   Khayal Tamer I Chief Commercial Officer   •       –      –    2022-11-15 4 AS $60.06 $255,495 D/D (4,254) 1,300 28%     
   Khayal Tamer I Chief Commercial Officer   •       –      –    2022-11-15 4 OE $2.21 $9,401 D/D 4,254 5,554     -
   Hassanein Waleed H President & CEO   •       •      –    2022-11-11 4 AS $60.03 $164,962 D/D (2,748) 440,768 35%     
   Khayal Tamer I Chief Commercial Officer   •       –      –    2022-11-11 4 AS $60.03 $162,201 D/D (2,702) 1,300 35%     
   Khayal Tamer I Chief Commercial Officer   •       –      –    2022-11-11 4 OE $2.21 $5,971 D/D 2,702 4,002     -
   Weill David Director   –       •      –    2022-11-10 4 S $56.00 $1,212,120 D/D (21,645) 13,500 -33%     
   Weill David Director   –       •      –    2022-11-10 4 OE $16.00 $346,320 D/D 21,645 35,145     -
   Hassanein Waleed H President & CEO   •       •      –    2022-11-07 4 AS $60.07 $166,334 D/D (2,769) 443,516 31%     
   Gordon Stephen Chief Financial Officer   •       –      –    2022-11-07 4 AS $56.72 $567,200 D/D (10,000) 5,714 31%     
   Gordon Stephen Chief Financial Officer   •       –      –    2022-11-07 4 OE $2.21 $151,259 D/D 10,000 15,714     -

  366 Records found
  1  2  3  4  5  6  7  8  9  Next   
  Page 7 of 15
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
  OE - Options Exercised A - Acquired
  IO - Initital Ownership D - Disposed